http://venturebeat.com/2007/09/05/life-sciences-briefing-wednesday-sept-5-2007/ News About Tech, Money and Innovation Tue, 24 Nov 2009 02:54:31 +0000 http://wordpress.org/?v=2.8.5 hourly 1 http://venturebeat.com/2007/09/05/life-sciences-briefing-wednesday-sept-5-2007/comment-page-1/#comment-562970 VentureBeat » Life sciences briefing: Thursday, Oct. 4, 2007 Thu, 04 Oct 2007 17:18:17 +0000 http://venturebeat.com/2007/09/05/life-sciences-briefing-wednesday-sept-5-2007/#comment-562970 [...] Hyperion, which raised $40 million in equity just a month ago (see our coverage in the first item here), in-licenses drug candidates from other companies and runs them through clinical trials. Its lead [...] [...] Hyperion, which raised $40 million in equity just a month ago (see our coverage in the first item here), in-licenses drug candidates from other companies and runs them through clinical trials. Its lead [...]

]]> http://venturebeat.com/2007/09/05/life-sciences-briefing-wednesday-sept-5-2007/comment-page-1/#comment-513998 VentureBeat » Hyperion Therapeutics raises $40M against GI and kidney disease Thu, 06 Sep 2007 04:10:44 +0000 http://venturebeat.com/2007/09/05/life-sciences-briefing-wednesday-sept-5-2007/#comment-513998 [...] our story on this South San Francisco, Calif., company in today’s daily briefing at VentureBeat Life [...] [...] our story on this South San Francisco, Calif., company in today’s daily briefing at VentureBeat Life [...]

]]>